Castle Biosciences Stock Filter Stocks by Fundamentals
| CSTL Stock | USD 16.54 0.85 4.89% |
Fundamental analysis of Castle Biosciences allows traders to better anticipate movements in Castle Biosciences' stock price by examining its financial health and performance throughout various phases of its business cycle.
Castle | Shares Owned by Institutions | Build AI portfolio with Castle Stock |
Castle Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Castle Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Castle Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Castle Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Castle Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Castle Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Castle Biosciences' value.| Shares | Geode Capital Management, Llc | 2025-03-31 | 649.9 K | Allianz Asset Management Ag | 2025-03-31 | 639.5 K | Schroder Investment Management Group | 2025-03-31 | 597.1 K | Park West Asset Management Llc | 2025-03-31 | 556.5 K | Palisade Capital Management Llc | 2025-03-31 | 490 K | Nuveen Asset Management, Llc | 2024-12-31 | 465.5 K | Bank Of America Corp | 2025-03-31 | 375.4 K | Braidwell Lp | 2025-03-31 | 365.2 K | Parkman Healthcare Partners Llc | 2025-03-31 | 350.6 K | Blackrock Inc | 2025-03-31 | 3 M | Vanguard Group Inc | 2025-03-31 | 2 M |
Castle Fundamentals
| Return On Equity | -0.012 | ||||
| Return On Asset | -0.018 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.32) % | ||||
| Current Valuation | 295.51 M | ||||
| Shares Outstanding | 28.87 M | ||||
| Shares Owned By Insiders | 2.98 % | ||||
| Shares Owned By Institutions | 93.02 % | ||||
| Number Of Shares Shorted | 1.6 M | ||||
| Price To Earning | 87.86 X | ||||
| Price To Book | 1.28 X | ||||
| Price To Sales | 1.38 X | ||||
| Revenue | 332.07 M | ||||
| Gross Profit | 284.39 M | ||||
| EBITDA | 38.14 M | ||||
| Net Income | 18.25 M | ||||
| Cash And Equivalents | 273.17 M | ||||
| Cash Per Share | 10.39 X | ||||
| Total Debt | 26.34 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 11.08 X | ||||
| Book Value Per Share | 15.27 X | ||||
| Cash Flow From Operations | 64.87 M | ||||
| Short Ratio | 3.05 X | ||||
| Earnings Per Share | (0.19) X | ||||
| Target Price | 35.89 | ||||
| Number Of Employees | 784 | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 477.55 M | ||||
| Total Asset | 531.24 M | ||||
| Retained Earnings | (200.13 M) | ||||
| Working Capital | 310.76 M | ||||
| Current Asset | 125.89 M | ||||
| Current Liabilities | 13.31 M | ||||
| Net Asset | 531.24 M |
About Castle Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Castle Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Castle Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Castle Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Castle Biosciences Piotroski F Score and Castle Biosciences Altman Z Score analysis. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth 0.206 | Return On Assets |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.